Thermo Fisher Scientific Inc (TMO) Financial Statements (2024 and earlier)

Company Profile

Business Address 168 THIRD AVENUE
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3829 - Measuring and Controlling Devices, Not Elsewhere Classified (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,1333,4828,5242,9191,8882,752
Cash and cash equivalents3,1333,4828,5242,9191,8882,752
Receivables8,0197,9228,1157,6717,7457,889
Inventory, net of allowances, customer advances and progress billings5,6555,6645,6345,7225,6685,483
Inventory5,6555,6645,6345,7225,6685,483
Contract with customer, asset, after allowance for credit loss1,4671,3751,3121,2481,1471,064
Other current assets1,7211,7661,6441,7391,6521,588
Total current assets:19,99520,20925,22919,29918,10018,776
Noncurrent Assets
Property, plant and equipment9,2929,3549,2808,6288,5298,448
Intangible assets, net (including goodwill)60,71061,11258,63858,30159,64461,099
Goodwill43,27343,14041,19640,48841,06641,721
Intangible assets, net (excluding goodwill)17,43717,97217,44217,81318,57819,378
Other noncurrent assets4,1083,9834,0074,3084,3064,424
Total noncurrent assets:74,11074,44971,92571,23772,47973,971
TOTAL ASSETS:94,10594,65897,15490,53690,57992,747
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,7334,1055,4766,1996,0304,301
Employee-related liabilities1,8641,7221,634
Accounts payable2,4232,7983,3812,4712,5862,667
Accrued liabilities1,3101,3072,0951,8641,722 
Deferred revenue2,5902,6622,6012,5672,7222,871
Debt4,8146,1225,5791,0101,0101,866
Other liabilities2,9752,9953,3543,2062,9573,032
Other undisclosed current liabilities    (1,864)(1,722) 
Total current liabilities:14,11215,88417,01011,11810,99712,070
Noncurrent Liabilities
Long-term debt and lease obligation, including:29,19429,13528,90928,15029,25031,389
Other undisclosed long-term debt and lease obligation29,19429,13528,90928,15029,25031,389
Liabilities, other than long-term debt6,8847,2067,0877,5417,8618,157
Deferred income tax liabilities2,8422,9762,8493,1403,3273,493
Other liabilities4,0424,2304,2384,4014,5344,664
Total noncurrent liabilities:36,07836,34135,99635,69137,11139,546
Total liabilities:50,19052,22553,00646,80948,10851,616
Temporary equity, carrying amount113123116119117113
Equity
Equity, attributable to parent43,75242,25743,97843,54942,29340,956
Common stock441441441440440440
Treasury stock, value(15,084)(15,083)(12,017)(11,011)(10,964)(10,961)
Additional paid in capital17,03016,88916,74316,59616,46716,292
Accumulated other comprehensive loss(2,924)(3,054)(3,099)(2,928)(2,724)(2,343)
Retained earnings44,28943,06441,91040,45239,07437,528
Equity, attributable to noncontrolling interest505354596162
Total equity:43,80242,31044,03243,60842,35441,018
TOTAL LIABILITIES AND EQUITY:94,10594,65897,15490,53690,57992,747

Income Statement (P&L) ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues10,68710,71011,45010,67710,97011,818
Cost of revenue(6,619)(6,026)(6,270)(6,408)(6,395)(5,741)
Gross profit:4,0684,6845,1804,2694,5756,077
Operating expenses(2,490)(3,121)(3,319)(2,559)(2,574)(3,256)
Operating income:1,5781,5631,8611,7102,0012,821
Nonoperating income (expense)1781001856464(145)
Investment income, nonoperating178146150683618
Other nonoperating income (expense) (46)35(4)28(163)
Interest and debt expense(326)(300)(269)(173)(148)(136)
Income from continuing operations before equity method investments, income taxes:1,4301,3631,7771,6011,9172,540
Loss from equity method investments(16)(25)(30)(72)(51)(19)
Income from continuing operations before income taxes:1,4141,3381,7471,5291,8662,521
Income tax expense(52)(46)(173)(31)(198)(301)
Income from continuing operations:1,3621,2921,5741,4981,6682,220
Income before gain (loss) on sale of properties:1,4981,6682,220
Net income:1,3621,2921,5741,4981,6682,220
Net income (loss) attributable to noncontrolling interest(1)(3)2(3)(4)(5)
Net income available to common stockholders, diluted:1,3611,2891,5761,4951,6642,215

Comprehensive Income ($ in millions)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income:1,3621,2921,5741,4981,6682,220
Other comprehensive income (loss) (1)1(773)(3)(382)(13)
Other undisclosed comprehensive income (loss)12447605(204)4(4)
Comprehensive income:1,4851,3401,4061,2911,2902,203
Comprehensive income (loss), net of tax, attributable to noncontrolling interest6(6)(1)(3)(7)(2)
Other undisclosed comprehensive income, net of tax, attributable to parent    3  
Comprehensive income, net of tax, attributable to parent:1,4911,3341,4051,2911,2832,201

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: